Amit Kumar Buys $17.3K of Anixa Biosciences Inc (ANIX) — SEC Form 4, Jul 21, 2026

Open-Market Net Purchase · SEC Form 4
+$17,300

Equity position changed by +0.8%

Reporting Owner
Amit Kumar
CEO
TXN 2026-07-20 · FILED 2026-07-21
Equity Position 641K sh 635,812 → 640,812
Equity Change +0.8% shares held after vs before
Filing Lag 1 business day within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership

Anixa Biosciences Inc

ANIX CIK 0000715446
All Anixa Biosciences Inc insider activity
Filing Date
2026-07-21
Report Date
2026-07-21
Accession No.
0001493152-26-034027
Accepted At
2026-07-21 14:23 UTC
Reporting Owner
Name Relationship
Amit Kumar CIK 0001191905
Director CEO
Amit Kumar at Anixa Biosciences Inc Full insider history
Bought (12 mo) $220,604
Sold (12 mo) —
More from this insider at Anixa Biosciences Inc
2026-11-02 Buy +$15,850 View
2026-10-22 Buy +$21,760 View
2026-09-28 Buy +$19,460 View
2026-09-14 Buy +$8,250 View
2026-09-11 Buy +$13,800 View
All filings by this insider at Anixa Biosciences Inc
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Common Stock 2026-07-20 P - Purchase 5,000 A $3.46 +$17,300 640,812 Direct

Related filings at Anixa Biosciences Inc

Institutional Holders
13F holders · Jun 30, 2026 64 institutional managers reporting a position
Largest by reported value
  1. Vanguard Capital Management Llc $3.72M
  2. Ubs Group Ag $1.64M
  3. Laird Norton Trust Company, Llc $1.62M
5%+ Holders · 13D/G 2 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Anixa Biosciences Inc
All Anixa Biosciences Inc insider activity
GET /v1/forms/4/0001493152-26-034027 API docs
View Original SEC Filing